Show Notes:
Healthcare is broken, and legacy incumbents have been notoriously slow to make changes. Seeing promising solutions in the startup ecosystem, today’s guest Jess Schram chose a career in venture capital to be closest to the companies at the cusp of healthcare innovation.
Jess is currently the Director of Investments & Incubations at Remedy Product Studio, having previously worked at Swiftarc Ventures investing in consumer tech and wellness companies improving access, affordability, and quality of care.
Finding a technical team is one of the greatest challenges healthcare founders face today. Remedy works directly with operating teams through equity-for-service deals—providing technical and product support. In doing so, Remedy takes a minority stake while building with a lead investor mindset.
In today’s episode, Jess and I discuss digital health trends, healthcare consumerization, and our country’s maternal mortality crisis.
Jess also assesses her health & wellness predictions from 2022 and makes new ones for 2024!
About Remedy Product Studio: Remedy is a product partner and strategic investor working on the strategy, execution, and launch of digital products with Seed to Series C companies.
About Swiftarc Ventures: Swiftarc is an early and growth-stage consumer and consumer health-focused venture capital firm.
Timestamps:
0:41: Jess’s path to venture
3:28: Energizing healthcare through innovation
5:19: Jess’s transition to Remedy Product Studio
10:02: Remedy’s “sweat-equity” model
14:31: Investing in digital health
17:42: Revisiting Jess’s healthcare predictions from 2022: Prediction 1
20:27: Prediction 2
24:08: Accuracy of wearable data
26:09: Prediction 3
28:19: Addressing barriers to care
31:53: Funding women’s health startups
35:29: Jess’s healthcare predictions for 2024
Resources Discussed:
Ep. 9: Jess Schram, Director of Investments & Incubations @ Remedy Product Studio on the Past, Present, and Future of Health & Wellness